Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide Plus Methotrexate in RA
NCT00563849Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of leflunomide in rheumatoid arthritis (RA), sponsored by Sanofi. Primary endpoint: American College of Rheumatology 20% Improvement at 20 weeks. Started May 2003; status: completed.
02
Drugs
leflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00563849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563849.